Fourth Quarter and Full Year 2025 Earnings EARNINGS PRESENTATION February 4, 2026 Forward Looking Statements and Non-GAAP Financial Measures FORWARD-LOOKING STATEMENTS Statements in this presentation that are not strictly historical, including statements regarding anticipated financial results, global and regional economic conditions, industry trends, geopolitical events, future acquisitions, impact of trade and spending policies, the ability to execute the planned strategies, interest rate and current exch ...

Financial Data and Key Metrics Changes - The company delivered total revenue of just over $1 billion, down 0.4% year over year, with core revenue declining 0.7% [18][20] - Adjusted EPS was $0.58, up 4% year over year, driven by stable adjusted EBITDA and lower interest expenses [20][21] - Free cash flow for Q2 was $180 million, with trailing twelve-month free cash flow of $939 million, representing a 14% year-over-year increase [21][30] Business Line Data and Key Metrics Changes - Intelligent Operating Solutions segment saw revenue and core revenue growth essentially flat year over year, with adjusted gross profit at $461 million, down slightly from the prior year [22][24] - Advanced Healthcare Solutions segment delivered total revenue of $320 million, down 1.3% year over year, with adjusted gross margins increasing from just under 58% to just over 59% [26][28] Market Data and Key Metrics Changes - North America showed slight positive growth, while Western Europe, China, and Latin America experienced year-over-year declines [19][20] - The company noted that customer demand pressures were influenced by macroeconomic factors, including tariff uncertainty and constrained government spending [7][19] Company Strategy and Development Direction - The company is focused on executing its Fortive Accelerated strategy, which includes innovation acceleration, commercial acceleration, and enhancing recurring customer value [11][12] - The company is initiating guidance for continuing operations, reflecting a full-year outlook consistent with its new approach of providing clear and simplified guidance [8][32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate macro pressures and emphasized the importance of the projects in the pipeline for government spending [50][51] - The company anticipates that the revenue slip experienced in Q2 will normalize in the coming quarters, with a strong outlook for the second half of the year [22][55] Other Important Information - The company received a $1.15 billion dividend from the Rallyant spinoff, which was used to pay down debt and fund share repurchases [30][31] - The gross tariff impact for Fortive's continuing operations is expected to be approximately $40 million to $55 million in 2025, with annualized impacts of $80 million to $120 million [29] Q&A Session Summary Question: Insights on second half moving pieces between Q3 and Q4 - Management confirmed that Q3 EPS is expected to be in the low to mid-50s range, with a sequential increase in Q4 driven by tax rate drops and tariff countermeasures [42][44] Question: Government spending and healthcare market outlook - Management noted that while government spending pressures exist, essential projects are still in the pipeline, and healthcare spending is expected to recover as reimbursement policies stabilize [50][51] Question: Clarification on organic sales growth expectations - Management indicated that organic sales growth in Q3 is expected to be consistent with the modest decline seen in Q2, with AHS facing high year-over-year comps [60][64] Question: Renewal rates for Gordian or iOS software - Management reported strong renewal rates across all software businesses, with a focus on expanding and cross-selling to enhance net dollar retention [67][68] Question: Rationale behind not providing high-level organic growth guidance - Management emphasized the intention to simplify communications with investors while maintaining focus on a multi-year value creation plan [73][74] Question: Approach to bolt-on acquisitions - Management clarified that there is a heightened level of scrutiny for bolt-on acquisitions, with a focus on ensuring that each deal meets high strategic and financial criteria [78][79]

Financial Data and Key Metrics Changes - The company delivered adjusted EPS of $0.90 for the final quarter as a consolidated entity, with an 8% growth in trailing twelve months adjusted free cash flow [7][8] - For continuing operations, adjusted EPS was $0.58, reflecting a 4% year-over-year increase, and trailing twelve months free cash flow grew 14% to $939 million [19][20] - Total revenue for Q2 was just over $1 billion, down 0.4% year-over-year, with core revenue declining 0.7% [17][18] Business Line Data and Key Metrics Changes - Intelligent Operating Solutions (IOS) segment saw flat revenue and core revenue growth year-over-year, with adjusted gross profit at $461 million, down slightly from the prior year [21][23] - Advanced Healthcare Solutions (AHS) segment reported total revenue of $320 million, down 1.3% year-over-year, with adjusted gross margins increasing from just under 58% to just over 59% [25][26] Market Data and Key Metrics Changes - North America showed slight positive growth, while Western Europe, China, and Latin America experienced year-over-year declines [18][19] - The company noted that customer demand pressures were influenced by macroeconomic factors, including tariff uncertainty and constrained government spending [7][18] Company Strategy and Development Direction - The company is focused on executing its "Fortive Accelerated" strategy, which aims to drive faster profitable growth and strong shareholder value creation [11][15] - The company is activating its bolt-on M&A engine with a disciplined approach to evaluate deals based on relative returns [15][76] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate macroeconomic challenges and emphasized the importance of their capital allocation strategy [15][34] - The company anticipates a modest gross margin and EPS headwind in Q3 due to ongoing tariff impacts, but expects to mitigate these by Q4 [27][30] Other Important Information - The company received a $1.15 billion dividend from the Rallyant spinoff, which was used to pay down debt and fund share repurchases [28][29] - The company initiated full-year adjusted EPS guidance for New Fortive at $2.5 to $2.6 per share, reflecting current market dynamics [30][32] Q&A Session Summary Question: What is the expected EPS for Q3 and Q4? - Management indicated that Q3 EPS is expected to be in the low to mid-50s range, with a potential increase in Q4 due to tax rate drops and other factors [41][45] Question: How are the main end markets expected to perform? - Management noted that government spending pressures and healthcare reimbursement uncertainties impacted Q2, but they expect improvements in the second half of the year [46][50] Question: What is the approach to guidance and disclosure moving forward? - The company plans to provide annual adjusted EPS guidance updated quarterly, focusing on clarity and simplification in communications with investors [72][73] Question: How is the company handling bolt-on M&A? - The company is ready to pursue bolt-on acquisitions with a heightened level of financial and strategic scrutiny, ensuring that each deal meets high standards [76][78]